Insights from 2023 ASH Annual Meeting

 

Myeloma
17:13

Insights from 2023 ASH Annual Meeting

Updates From ASH: The Evolving Role and Sequencing of Bispecifics and CAR-T in Myeloma

FEATURING Andrzej Jakubowiak
  • 235 views
  • February 17, 2024
08:11

Insights from 2023 ASH Annual Meeting

Triple-Class-Exposed R/R MM: Results From the KarMMa-3 Trial of Ide-Cel vs. Standard Regimens

FEATURING Krina Patel
  • 107 views
  • February 12, 2024
  • 1
19:08

Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGUS From ASH"

FEATURING Rahul Banerjee
  • 814 views
  • January 31, 2024
  • 4
04:30

Insights from 2023 ASH Annual Meeting

High-Risk NDMM: KarMMa-2 Extended Follow-Up - Ide-Cel in HR-NDMM Patients With Inadequate Response to Frontline AutoSCT

FEATURING Melissa Alsina
  • 84 views
  • January 24, 2024
16:42

Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of Myeloma - Highlights & Key Takeaways"

FEATURING Hamza Hashmi
  • 1,469 views
  • January 19, 2024
  • 6
19:24

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Updates on Managing Newly Diagnosed MM - Incorporating Data From ASH"

FEATURING Paul Richardson
  • 743 views
  • January 18, 2024
  • 5
06:44

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Sonrotoclax Combined With Dexamethasone for the Treatment of t(11;14)+ R/R MM"

FEATURING Hang Quach
  • 64 views
  • January 17, 2024
06:55

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Selinexor and Lenalidomide vs. Lenalidomide Maintenance Post-ASCT for Pts With NDMM"

FEATURING Hang Quach
  • 20 views
  • January 17, 2024
05:03

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Teclistamab in R/R MM - A Multi-Institutional Real-World Study"

FEATURING Rajshekhar Chakraborty
  • 226 views
  • January 16, 2024
  • 1
15:13

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Mezigdomide + Dex + Dara or Elo in Pts With R/R MM - Results From CC-92480-MM-002"

FEATURING Paul Richardson
  • 130 views
  • January 16, 2024
  • 1
09:05

Insights from 2023 ASH Annual Meeting

RRMM: Effects of Ide-Cel vs. Standard Regimens on HRQoL in Patients Who Had Received 2-4 Prior Regimens - Updated Results From KarMMa-3

FEATURING Michel Delforge
  • 166 views
  • January 8, 2024
09:39

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Impact of Dex Dose Strength on Outcomes in NDMM"

FEATURING Rahul Banerjee
  • 217 views
  • December 29, 2023
  • 2
04:37

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Early Peripheral Blood MRD Status by NGS in Pts With NDMM From a Ph2 Trial of Elo-KRd"

FEATURING Ben Derman
  • 96 views
  • December 29, 2023
06:19

Insights from 2023 ASH Annual Meeting

Dara-KRd in NDMM Without ASCT: Final Analysis of a Ph2 Trial

FEATURING Ben Derman
  • 604 views
  • December 29, 2023
  • 2
12:32

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Early Benefits and Psychological Effects of Screening for MGUS - Results From the IstopMM Study"

FEATURING Sæmundur Rögnvaldsson
  • 61 views
  • December 29, 2023
10:03

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "MGUS and the Risk of Thrombotic Events - Results from IstopMM"

FEATURING Sæmundur Rögnvaldsson
  • 12 views
  • December 29, 2023
10:53

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "RVd vs. RVd Plus ASCT in African Americans With NDMM From the Ph3 DETERMINATION Trial"

FEATURING Jeffrey Zonder
  • 3 views
  • December 27, 2023
17:46

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Highlights in 1L MM - Quadruplet Therapies on a Roll"

FEATURING Andrzej Jakubowiak
  • 1,391 views
  • December 22, 2023
  • 5
08:36

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Standard- and High-Risk ND Transplant-Eligible MM Pts Treated With RVD vs. Dara-RVD"

FEATURING Nisha Joseph
  • 454 views
  • December 22, 2023
  • 1
10:06

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Outcomes After CAR-T in MM Patients With Extramedullary and Paramedullary Disease"

FEATURING Darren Pan
  • 41 views
  • December 22, 2023
06:14

Insights from 2023 ASH Annual Meeting

Multiple Myeloma: Inflammatory Biomarkers and Outcomes CAR T-Cell Therapy

FEATURING Darren Pan
  • 63 views
  • December 22, 2023
12:37

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "GMMG ReLApsE Trial - Salvage Auto Transplant & Len Maintenance vs. Continuous Len/Dex for R/R MM"

FEATURING Marc-Andrea Bärtsch
  • 55 views
  • December 22, 2023
10:23

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "iStopMM Study - Revised Definition of Free Light Chains in Serum & Light Chain MGUS"

FEATURING Thorir Einarsson Long
  • 139 views
  • December 22, 2023
07:27

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Dual Targeting of SLAMF-7 and CD38 - A Ph2 Study of Isatuximab, Elotuzumab, Pomalidomide and Dexamethasone in R/R MM"

FEATURING Binod Dhakal
  • 398 views
  • December 21, 2023
  • 1
03:14

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "MyDRUG Sub-Protocol Y3 Results - Selinexor, Ixazomib, Pomalidomide, & Dexamethasone in Functionally High-Risk MM"

FEATURING Joshua Richter
  • 119 views
  • December 20, 2023
08:51

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Outpatient Management of CAR-T and Bi-Specific Antibodies for Patients With Lymphoma and MM"

FEATURING Radhika Bansal
  • 449 views
  • December 19, 2023
12:03

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Daratumumab Monotherapy in Newly Diagnosed Stage 3B Light-Chain Amyloidosis - A European Myeloma Network Study"

FEATURING Efstathios Kastritis
  • 134 views
  • December 18, 2023
  • 1
22:14

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "RW Safety & Efficacy of Teclistamab for Pts With Heavily Pretreated R/R MM"

FEATURING Danai Dima
  • 223 views
  • December 18, 2023
09:22

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "DREAMM-6 Trial Arm-A - Belantamab Mafodotin Combined With Lenalidomide + Dex in Patients With R/R MM"

FEATURING Rakesh Popat
  • 34 views
  • December 17, 2023
14:08

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "MonumenTAL-1 Study - Talquetamab in Pts With R/R MM Previously Exposed to T-Cell Redirecting Therapies"

FEATURING Andrzej Jakubowiak
  • 135 views
  • December 17, 2023
06:06

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "BMS-986393 (CC-95266), an Autologous GPRC5D-Targeted CAR T-Cell Therapy for R/R MM - Ph1 Study Results"

FEATURING Susan Bal
  • 47 views
  • December 15, 2023
04:55

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "iStopMM Study - Risk Factors of Smoldering Multiple Myeloma"

FEATURING Sigrun Thorsteinsdottir
  • 155 views
  • December 14, 2023
07:20

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in High-Risk SMM"

FEATURING Omar Nadeem
  • 84 views
  • December 13, 2023
10:36

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Immuno-PRISM Study of Bispecific Antibodies in High-Risk SMM"

FEATURING Omar Nadeem
  • 90 views
  • December 13, 2023
11:55

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "CENTAURUS Study Final Analysis - Efficacy & Safety of Dara Monotherapy in Pts With Intermediate- or High-Risk SMM"

FEATURING Ola Landgren
  • 272 views
  • December 13, 2023
  • 2